Core Insights - Enphase Energy Inc. reported a significant year-on-year growth in net income and revenues for the previous year, with net income increasing by 68% to $172 million and revenues rising by 10.5% to $1.47 billion [1] - However, the company's fourth-quarter performance showed a decline in net income by 37.7% to $38.7 million and a decrease in net revenues by 10.4% to $343 million compared to the previous year [3] - Looking forward, Enphase Energy is projecting revenues between $270 million and $300 million for the upcoming quarter, indicating a decline of 16% to 24% from the previous quarter's revenue of $356.1 million [3] Financial Performance - The gross margin for Enphase Energy is expected to be between 40% and 43%, which includes an impact of approximately five percentage points from reciprocal tariffs [4] - Investment firms RBC Capital and Wells Fargo have upgraded their ratings for Enphase Energy, with RBC raising its price target to $54 from $31 and Wells Fargo increasing its target to $50 from $45 [4]

Core Viewpoint - Western Midstream Partners, LP (NYSE:WES) is recognized as one of the best pipeline and MLP stocks to buy in 2026, indicating strong market confidence in its future performance [1]. Group 1: Ratings and Price Targets - RBC Capital's Elvira Scotto reiterated a Hold rating on WES with a price target of $42 as of January 28, 2026, while Morgan Stanley maintained a Sell rating with a price target of $41 [2]. Group 2: Financial Performance - Western Midstream Partners declared a quarterly cash distribution of $0.91 per unit for Q4 2025, consistent with the previous quarter's payout, with eligibility for shareholders as of February 2, 2026, for payment on February 13, 2026 [3]. Group 3: Strategic Developments - The company announced renegotiations on key natural gas contracts in the Delaware Basin with Occidental and ConocoPhillips, transitioning to simplified, fixed-fee arrangements. Occidental will transfer 15.3 million WES common units, valued at approximately $610 million, back to the partnership for redemption, aiming to solidify revenue through the late 2030s and diversify its customer base [4]. Group 4: Company Overview - Founded in 2007, Western Midstream Partners, LP is a master limited partnership focused on the gathering, processing, and transportation of natural gas, crude oil, and NGLs across major U.S. basins, utilizing fee-based contracts, and is headquartered in Texas [5].

January was a rough month for Oracle (NYSE: ORCL) investors. The enterprise software giant saw its stock fall 15.6%, continuing its slide from a less-than-stellar earnings report released the month prior. Three major factors were at play: a bondholder lawsuit, a wave of analyst downgrades and price cuts, and a macro environment that turned hostile to AI infrastructure spending. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now, when y ...

Marvell Technology, Inc. (NASDAQ:MRVL) is one of the 10 AI Stocks Analysts Are Watching. On February 2, RBC Capital analyst Srini Pajjuri reiterated an Outperform rating on the stock with a $105.00 price target. The firm remains confident in MRVL’s long-term AI infrastructure thesis despite near-term EPS dilution. RBC Capital particularly updated MRVL’s estimates after the completion of the Celestial AI acquisition. The updated estimates align with management’s guidance, the firm noted, adding that it co ...

Group 1 - Venture Global, Inc. (NYSE:VG) is considered one of the best undervalued stocks to buy under $10, with RBC Capital cutting the price target to $11 from $13 while maintaining an Outperform rating [1] - JPMorgan downgraded Venture Global, Inc. to Neutral from Overweight, raising the price target to $11 from $10, citing a negative revision to its 2025 adjusted EBITDA guidance [3] - The revisions from JPMorgan indicate Venture Global's high sensitivity to short-term pricing, with expectations of continued price uncertainty for liquefied natural gas due to near-term supply additions [4] Group 2 - KeyBanc noted that production curtailments and commodity prices are driving changes in estimates for the natural gas sector, with RBC Capital favoring the natural gas growth story despite recent underperformance [2]

Company Overview - 3M Company (NYSE:MMM) is one of the largest industrial conglomerates globally [2] - The shares have increased by 1.28% over the past year but have decreased by 3.4% year-to-date [2] Analyst Ratings - JPMorgan downgraded 3M's shares to Neutral from Overweight in January, setting a price target of $128 [2] - RBC Capital raised the price target for 3M to $136 from $131 while maintaining an Underperform rating [2] Performance Insights - 3M's shares have outperformed their sector since early 2024, according to JPMorgan [2] - Recent selling pressure on 3M's shares was attributed to weakness in the consumer business [2] Legal and Operational Challenges - Potential headwinds for 3M include PFAS litigation, which encompasses several litigation categories [2] - The company faces a complicated road ahead in driving innovation across its business [2] Market Commentary - Jim Cramer defended 3M after its earnings report, suggesting that the company's performance was misjudged [3]

Group 1 - Marvell Technology, Inc. (NASDAQ:MRVL) is recognized as a promising stock within the QQQ index, with RBC Capital initiating coverage and assigning an Outperform rating along with a price target of $105, highlighting its strong position in the data center sector [1] - The company has secured significant contracts for AWS Trainium3 chips and completed the acquisition of Celestial, reinforcing its role as a key ASIC supplier for Trainium 4 [1] - Analyst Srini Pajjuri noted that Marvell's optical division is stable, while also identifying scale-up and custom SmartNICs as underappreciated growth opportunities [2] Group 2 - Marvell Technology signed a definitive agreement to acquire XConn Technologies for approximately $540 million, which will be financed through a mix of cash and about 2.5 million shares of MRVL common stock [2] - The company is primarily focused on semiconductor development and manufacturing, particularly in the data center market [3]

Core Viewpoint - N-Able Inc. (NYSE:NABL) is receiving positive recommendations from analysts, highlighting its potential in the business tech sector, particularly in managed services for small businesses [1][2]. Group 1: Analyst Recommendations - B. Riley initiated coverage on N-Able with a Buy rating and a $10 price target, citing expected demand growth for software-based managed services [1]. - RBC Capital's Matthew Hedberg also reaffirmed a Buy rating and a $10 price target for N-Able, indicating a consensus among analysts regarding the stock's potential [2]. Group 2: Company Overview - N-Able Inc. is a cloud-based software company that provides services such as backup and data protection, remote monitoring and management, and threat hunting, primarily targeting small- and medium-sized businesses [2]. Group 3: Market Position and Trends - The company is positioned to benefit from the increasing demand for managed services, particularly in security and data protection, driven by advancements in artificial intelligence [1]. - N-Able has maintained healthy margins and cash flows, which supports its competitive advantage in the market [1].

We recently published 14 Stocks on Jim Cramer’s Radar.  GE Aerospace (NYSE:GE) is one of the stocks on Jim Cramer's radar. GE Aerospace (NYSE:GE) is one of the largest aerospace companies in the world. Its shares are up by 51% over the past year and down by 8% year-to-date. The firm has been at the center of attention by multiple analysts after it reported its fiscal fourth quarter earnings report. For instance, JPMorgan raised GE Aerospace (NYSE:GE)’s share price target to $335 from $325 and kept an Over ...

Core Viewpoint - DexCom Inc. is viewed as a strong investment opportunity for 2026, despite recent downgrades and mixed analyst ratings [1][2][3] Group 1: Analyst Ratings and Price Targets - Barclays downgraded DexCom to Underweight from Equal Weight with a reduced price target of $71, down from $80, citing increased competition in core insulin-intensive segments [1] - Bernstein raised its price target for DexCom to $86 from $84 while maintaining an Outperform rating, indicating a positive outlook as healthcare stocks recover [2] - RBC Capital maintained a Buy rating on DexCom with a price target of $85, reflecting confidence in the company's performance [3] Group 2: Market Context and Competition - The healthcare sector is showing signs of recovery after a low point in September 2025, which may benefit DexCom as macroeconomic uncertainties diminish [2] - Intensifying competition in DexCom's primary segments is expected to limit its stock valuation multiple and hinder performance in the near-to-medium term [1]